Insiders Blueprint Medicines Corporation
Equities
BPMC
US09627Y1091
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
95.50 USD | -0.49% | -2.24% | +3.46% |
Nov. 22 | Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing | MT |
Nov. 14 | JPMorgan Initiates Blueprint Medicines at Overweight With $126 Price Target | MT |
Insiders
Nov. 22 | MT | |
Oct. 04 | MT | |
Aug. 07 | MT | |
Jun. 25 | MT | |
Jun. 07 | MT | |
Jun. 05 | MT | |
Jun. 04 | MT | |
May. 06 | MT | |
Mar. 22 | MT | |
Mar. 01 | MT | |
Dec. 13 | MT | |
Dec. 11 | MT | |
Dec. 04 | MT | |
Nov. 28 | MT | |
Nov. 03 | MT | |
23-10-05 | MT | |
23-09-29 | MT | |
23-08-29 | MT | |
23-01-06 | CI | |
22-12-08 | MT | |
22-08-23 | MT | |
22-08-19 | MT | |
22-06-23 | CI | |
22-06-08 | MT | |
22-05-18 | MT |